The dramatic increase in breast cancer incidence compels a paradigm shift in our preventive efforts. There are several barriers to overcome before prevention becomes an established part of breast cancer management. The objective of this review is to identify the clinical challenges for improved breast cancer prevention and discuss current knowledge on breast cancer risk assessment methods, risk communication, ethics, and interventional efforts with the aim of covering the aspects relevant for a breast cancer prevention trial. Herein, the following five areas are discussed: (i) Adequate tools for identification of women at high risk of breast cancer suggestively entitled Prevent! Breast cancer is the most common cancer in women worldwide with a steady increase in incidence, particularly in the developing world (1-3). An expanding middle class and a more westernized lifestyle contribute to increasing breast cancer rates in less developed countries as well (4-7), while limited health care resources and insufficient infrastructure challenge the management of the rising number of breast cancer patients (8). The dramatic increase in breast cancer incidence compels a paradigm shift in our preventive efforts. Despite the increasing incidence, few preventive measures have been implemented apart from identification and surveillance of genetically identified high-risk women with BRCA1 and BRCA2 mutations (9). Early detection through mammography screening and treatment of newly diagnosed cancers represent current clinical standards. There are several barriers to overcome before prevention becomes an established part of breast cancer management (Table 1). Consequently, the success of prevention efforts relies strongly on an ambitious interdisciplinary approach dedicated to the potential high-yield gain of intercepting breast cancer development (10).The initiative to this review originated while preparing a breast cancer prevention trial and identifying the gap of comprehensively bridging, not only risk assessment and intervention, but also communication of risk. Thus, the objective of this review is to identify the clinical challenges for improved breast cancer prevention and discuss current knowledge on breast cancer risk assessment methods, risk communication, ethics, and interventional efforts with the aim of covering aspects relevant for a prevention trial. Future comprehensive risk prediction models and effective communication hereof hopefully will allow for state-ofthe-art identification of high-risk women among whom individualized surveillance and prevention through adequate intervention can reduce breast cancer incidence.
Breast Cancer Risk Prediction ModelsCurrent breast cancer risk assessment tools and prediction modelsThe identification of women at increased risk for developing breast cancer improves the likelihood these women will benefit from intensified surveillance and/or preventive intervention. Risk assessment systems have been developed successfully for women with a strong family history of breast c...